ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 35 filers reported holding ONCOLYTICS BIOTECH INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,319 | -16.2% | 5,651 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $14,693 | +116.7% | 5,651 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $6,781 | -26.4% | 5,651 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $9,211 | +31.6% | 5,651 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $7,000 | +16.7% | 5,651 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | -33.3% | 5,651 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $9,000 | +12.5% | 5,651 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $8,000 | -33.3% | 5,651 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $12,000 | -25.0% | 5,651 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $16,000 | -27.3% | 5,651 | 0.0% | 0.01% | -28.6% |
| Q1 2021 | $22,000 | +69.2% | 5,651 | 0.0% | 0.01% | +40.0% |
| Q4 2020 | $13,000 | +30.0% | 5,651 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $10,000 | -9.1% | 5,651 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $11,000 | +37.5% | 5,651 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $8,000 | -70.4% | 5,651 | 0.0% | 0.00% | -63.6% |
| Q4 2019 | $27,000 | – | 5,651 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 277,852 | $885,000 | 0.08% |
| CHIRON CAPITAL MANAGEMENT, LLC | 10,000 | $38,000 | 0.03% |
| BRAVE ASSET MANAGEMENT INC | 10,000 | $38,000 | 0.01% |
| Disciplined Investments, LLC | 5,189 | $20,000 | 0.01% |
| Cedar Mountain Advisors, LLC | 5,651 | $22,000 | 0.01% |
| Crescent Grove Advisors, LLC | 10,000 | $38,000 | 0.00% |
| SITTNER & NELSON, LLC | 1,000 | $4,000 | 0.00% |
| Banque Cantonale Vaudoise | 11,268 | $42,000 | 0.00% |
| Zions Bancorporation, N.A. | 5,000 | $19,000 | 0.00% |
| CIBC WORLD MARKET INC. | 61,992 | $236,000 | 0.00% |